3-(4-Fluorophenyl)-1-isopropyl-1H-indole | CAS:93957-49-4

We serve 3-(4-Fluorophenyl)-1-isopropyl-1H-indole CAS:93957-49-4 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.
3-(4-Fluorophenyl)-1-isopropyl-1H-indole

Chemical Name:3-(4-Fluorophenyl)-1-isopropyl-1H-indole
CAS.NO:93957-49-4
Synonyms:3-(4-Fluorophenyl)-1-isopropyl-1H-indole
1-Isopropyl-3-(4-fluorophenyl)-indole
3-(4-fluorophenyl)-1-propan-2-ylindole
3-(4-Fluorophenyl)-1-(propan-2-yl)-1H-indole
 
Physical and Chemical Properties:
Density 1.1±0.1 g/cm3
Boiling Point 389.6±25.0 °C at 760 mmHg
Melting Point 96-97°C
Molecular Formula C17H16FN
Molecular Weight 253.314
Flash Point 189.4±23.2 °C
Vapour Pressure 0.0±0.9 mmHg at 25°C
Index of Refraction 1.573
 
Specification:
Appearance:Off-white crystalline powder
Assay:≥98.0%
 
Packing:25 kg/drum, can also be packaged according to customer requirements
Storage:Store in a cool, ventilated place
Application:Intermediate of Fluvastatin(CAS:93957-54-1).



Contact us for information like 3-(4-Fluorophenyl)-1-isopropyl-1H-indole chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,3-(4-Fluorophenyl)-1-(propan-2-yl)-1H-indole physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,3-(4-fluorophenyl)-1-propan-2-ylindole Use and application,3-(4-fluorophenyl)-1-propan-2-ylindole technical grade,usp/ep/jp grade.


Related News: “Inceptua Medicines Access is delighted to be selected as Onconova’s partner for the Pre-approval Access Program for rigosertib.1-iodo-4-methoxybenzene manufacturer “Inceptua Medicines Access is delighted to be selected as Onconova’s partner for the Pre-approval Access Program for rigosertib.2-Bromodibenzo[b,d]furan supplier The market for pharmaceutical intermediates is vast and is expected to usher in new growth. Compared with the pesticide intermediate business, the market space for pharmaceutical intermediates is larger and will be the focus of the company’s future development.1-IODO-3-FLUOROPROPANE vendor The target screening performed by Retrogenix will focus on hundreds of novel, prioritized antibodies in Resonant’s collection.Coronaviruses (CoV) are a large family of viruses that cause illness ranging from the common cold to more severe diseases such as Middle East Respiratory Syndrome (MERS-CoV) and Severe Acute Respiratory Syndrome (SARS-CoV). A novel coronavirus (nCoV) is a new strain that has not been previously identified in humans.